Login or Sign Up
Concord Biotech Ltd. Corporate Actions
15:58 Jun 12
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd. Corporate Actions
Concord Biotech Ltd.
Industry Biotechnology
15:58 Jun 12
Quality
68/100
High Financial Strength
Valuation
27/100
Expensive Valuation
Technical
51/100
Technically Neutral
Strength
14
Weakness
3
Opportunity
1
Threats
0
0.42 %
Dividend Yield
21.59K
Market Cap (Cr)
84.38
RSI
44.08 %
Promoter Holding
30.96 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 21-Jun-2024 | Dividend | 8.75/share@875.00% | 22-Jun-2024 | 875.00 | Final |
Download Our App On:
Back
OTP sent to your mobile number/email. Please enter it below to verify.
